Loxagen

Platform for Lipoxygenase Small Molecule Inhibitors.

Health and bioBerkeley SkyDeck

Website: loxagen.com.

Category: Health and bio.

Sectors: Biotechnology, Life Science, Therapeutics.

Based in: Palo Alto, United States.

On Recent Funding since: Sep 28, 2026.

Signals

Website registeredJun 22, 2020 (6 years old)

About Loxagen

Lipoxygenases play a central role in driving pathways in cardiovascular and metabolic diseases. We translate deep mechanistic discoveries into innovative, IND-ready therapies.

Timeline

June 22, 2020
Website created
Batch 12
BBerkeley SkyDeck · batch
Source: skydeck.berkeley.edu

Founders and team

KC
Kalidip Choudhury CEO/Co-founder

source: loxagen.com
MH
Michael Holinstat Scientific Founder

source: loxagen.com
TH
Theodore Holman Scientific Founder

source: loxagen.com

Investors

Companies like Loxagen

SStorm Therapeutics$56M Series B+ · Apr 2026
MMwyngil TherapeuticsSeed · Jun 2026
LLoQus23Series A · Oct 2024
SSleptaySeries A · Sep 2026
RRougeTx$58M Series A · Oct 2026
RRevier Therapeutics$6.95M Seed · Aug 2026

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/loxagen-inc (get a free API key).